etoposide phosphate and Hematologic Malignancies

etoposide phosphate has been researched along with Hematologic Malignancies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dowling, M; Grigg, A; Janson, B; Khot, A; Siderov, J; Stewart, T; Xie, J1
Barnoud, D; Barthélémy, C; Béné, J; Bruno, B; Décaudin, B; Gautier, S; Lahoche, A; Odou, P; Petitpain, N; Pinçon, C; Simon, N; Vasseur, M1

Other Studies

2 other study(ies) available for etoposide phosphate and Hematologic Malignancies

ArticleYear
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass index.
    Leukemia & lymphoma, 2023, Volume: 64, Issue:1

    Topics: Acute Kidney Injury; Body Mass Index; Etoposide; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning

2023
Acute kidney injury after high dose etoposide phosphate: A retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:7

    Topics: Acute Kidney Injury; Antineoplastic Agents; Child; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphorus Compounds; Prognosis; Retrospective Studies; Survival Rate; Transplantation Conditioning

2018